Published in J Clin Invest on August 01, 1981
Docosahexaenoic acid is a strong inhibitor of prostaglandin but not leukotriene biosynthesis. Proc Natl Acad Sci U S A (1983) 1.67
Long-term effects of dietary marine omega-3 fatty acids upon plasma and cellular lipids, platelet function, and eicosanoid formation in humans. J Clin Invest (1985) 1.64
Arachidonate metabolism in vascular disorders. J Clin Invest (1983) 1.43
Dietary fish oil modulates macrophage fatty acids and decreases arthritis susceptibility in mice. J Exp Med (1985) 1.41
Ability of the xid gene to prevent autoimmunity in (NZB X NZW)F1 mice during the course of their natural history, after polyclonal stimulation, or following immunization with DNA. J Clin Invest (1982) 1.30
Docosahexaenoic acid-enriched fish oil attenuates kidney disease and prolongs median and maximal life span of autoimmune lupus-prone mice. J Immunol (2010) 1.22
Dietary omega-3 polyunsaturated fatty acids inhibit phosphoinositide formation and chemotaxis in neutrophils. J Clin Invest (1993) 1.17
Leukotriene B5 is formed in human neutrophils after dietary supplementation with icosapentaenoic acid. Proc Natl Acad Sci U S A (1985) 1.10
Nutrition and autoimmunity: a review. Clin Exp Immunol (1986) 1.09
The role of omega-3 dietary supplementation in blepharitis and meibomian gland dysfunction (an AOS thesis). Trans Am Ophthalmol Soc (2008) 1.03
Essential fatty acid deficiency depletes rat glomeruli of resident macrophages and inhibits angiotensin II-induced eicosanoid synthesis. J Clin Invest (1987) 1.02
Dietary n-3 fatty acid effects on neutrophil lipid composition and mediator production. Influence of duration and dosage. J Clin Invest (1993) 0.99
Increased renal thromboxane production in murine lupus nephritis. J Clin Invest (1986) 0.95
Treatment of rheumatoid arthritis with marine and botanical oils: influence on serum lipids. Evid Based Complement Alternat Med (2011) 0.87
Differences in the occurrence of hypertension among (NZB X NZW)F1, MRL-lpr, and BXSB mice with lupus nephritis. Am J Pathol (1984) 0.87
The type of dietary fat affects the severity of autoimmune disease in NZB/NZW mice. Am J Pathol (1987) 0.86
Essential fatty acid deficiency prevents multiple low-dose streptozotocin-induced diabetes in CD-1 mice. Proc Natl Acad Sci U S A (1988) 0.85
Neutrophil oxygen radical generation. Synergistic responses to tumor necrosis factor and mono/polyunsaturated fatty acids. J Clin Invest (1996) 0.85
Eicosapentaenoic acid inhibits antigen-presenting cell function of murine splenocytes. Immunology (1992) 0.82
Murine glomerular leukotriene B4 synthesis. Manipulation by (n-6) fatty acid deprivation and cellular origin. J Clin Invest (1988) 0.81
Transcription of the murine iNOS gene is inhibited by docosahexaenoic acid, a major constituent of fetal and neonatal sera as well as fish oils. J Exp Med (1996) 0.80
Effects of dietary supplementation on autoimmunity in the MRL/lpr mouse: a preliminary investigation. Ann Rheum Dis (1986) 0.80
Inhibition of intracellular peroxides and apoptosis of lymphocytes in lupus-prone B/W mice by dietary n-6 and n-3 lipids with calorie restriction. J Clin Immunol (2002) 0.78
The calciotropic hormone response to omega-3 supple-mentation during long-term weight-bearing exercise training in post menopausal women. J Sports Sci Med (2010) 0.78
Effects of altering the eicosanoid precursor pool on neovascularization and inflammation in the alkali-burned rabbit cornea. Am J Pathol (1990) 0.77
Enhanced production of IgE and IgG antibodies associated with a diet enriched in eicosapentaenoic acid. Immunology (1982) 0.76
Effects of aspirin, dipyridamole, and cod liver oil on accelerated myointimal proliferation in canine veno-arterial allografts. Ann Surg (1988) 0.76
Effects of n-3 fatty acid, fructose-1,6-diphosphate and glutamine on mucosal cell proliferation and apoptosis of small bowel graft after transplantation in rats. World J Gastroenterol (2003) 0.76
Eicosapentaenoic Acid suppresses the proliferation of synoviocytes from rheumatoid arthritis. J Clin Biochem Nutr (2008) 0.75
New approaches to treating systemic lupus erythematosus. West J Med (1987) 0.75
Fish oil supplements, longevity and aging. Aging (Albany NY) (2016) 0.75
Effects of calorie restriction and ω-3 dietary fat on aging in short-and long-lived rodents. Age (Omaha) (1998) 0.75
Risk of secondary lymphedema in breast cancer survivors is related to serum phospholipid fatty acid desaturation. Support Care Cancer (2016) 0.75
Pathogenesis of the glomerulonephritis of NZB/W mice. J Exp Med (1968) 8.91
Control of vascular permeability by polymorphonuclear leukocytes in inflammation. Nature (1981) 6.36
Eicosapentaenoic acid and prevention of thrombosis and atherosclerosis? Lancet (1978) 3.74
The ratio of trienoic: tetraenoic acids in tissue lipids as a measure of essential fatty acid requirement. J Nutr (1960) 2.71
Influence of diet on survival of mice. Proc Natl Acad Sci U S A (1976) 2.45
The composition of food consumed by Greenland Eskimos. Acta Med Scand (1976) 2.27
Mediators of immediate hypersensitivity derived from arachidonic acid. N Engl J Med (1980) 1.83
Prostaglandins as mediators of inflammation. Adv Prostaglandin Thromboxane Res (1976) 1.48
Dietary restrictions early and late: effects on the nephropathy of the NZB X NZW mouse. Lab Invest (1978) 1.45
Prevention of glomerulonephritis and prolonged survival in New Zealand Black/New Zealand White F1 hybrid mice fed an essential fatty acid-deficient diet. J Clin Invest (1981) 1.41
Prostaglandin E treatment of NZB/NZW mice. Arthritis Rheum (1977) 1.38
Nucleic acid antibodies in African trypanosomiasis: studies in Rhesus monkeys and man. J Immunol (1974) 1.32
Prostaglandin E1 treatment of NZB/NZW F1 hybrid mice. II. Prevention of glomerulonephritis. Arthritis Rheum (1977) 1.29
Acute anti-inflammatory effects of aspirin and dexamethasone in rats deprived of endogenous prostaglandin precursors. J Pharm Pharmacol (1977) 1.18
Modification of adjuvant inflammation in rats deficient in essential fatty acids. Agents Actions (1976) 1.06
Animal models of human systemic lupus erythematosus. Yale J Biol Med (1979) 1.02
Triene prostaglandins: prostaglandin D3 and icosapentaenoic acid as potential antithrombotic substances. Proc Natl Acad Sci U S A (1979) 1.02
Therapeutic studies in NZB/W mice. III. Relationship between renal status and efficacy of immunosuppressive drug therapy. Arthritis Rheum (1975) 1.00
The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus. Arch Neurol (1989) 13.32
Production of collagenase and prostaglandins by isolated adherent rheumatoid synovial cells. Proc Natl Acad Sci U S A (1976) 5.40
Ly-1 B cells: functionally distinct lymphocytes that secrete IgM autoantibodies. Proc Natl Acad Sci U S A (1984) 5.15
Therapy of lupus nephritis. Controlled trial of prednisone and cytotoxic drugs. N Engl J Med (1986) 4.01
Effect of dietary enrichment with eicosapentaenoic and docosahexaenoic acids on in vitro neutrophil and monocyte leukotriene generation and neutrophil function. N Engl J Med (1985) 4.00
The pathogenesis of autoimmunity in New Zealand black mice. Curr Top Microbiol Immunol (1974) 3.98
X-linked B-lymphocyte immune defect in CBA/HN mice. I. Studies of the function and composition of spleen cells. J Exp Med (1975) 3.70
Prostaglandin-stimulated bone resorption by rheumatoid synovia. A possible mechanism for bone destruction in rheumatoid arthritis. J Clin Invest (1975) 3.24
Immunoregulatory aberrations in systemic lupus erythematosus. J Immunol (1978) 3.07
Cytokine gene expression after in vivo primary immunization with goat antibody to mouse IgD antibody. J Immunol (1991) 3.04
X-linked B-lymphocyte immune defect in CBA/N mice. II. Studies of the mechanisms underlying the immune defect. J Exp Med (1975) 3.03
Incorporation of tritium from [(4R)-4-3H]mevalonate into abscisic acid. Biochem J (1969) 3.01
The genetics of the immune response to a synthetic double-stranded RNA in a mutant CBA mouse strain. J Immunol (1973) 3.00
Biosynthesis of abscisic acid: incorporation of radioactivity from [2-14C]mevalonic acid by intact fruit. Biochem J (1969) 2.97
Failure of autologous mixed lymphocyte reactions between T and non-T cells in patients with systemic lupus erythematosus. Proc Natl Acad Sci U S A (1978) 2.94
Effects of thymectomy or androgen administration upon the autoimmune disease of MRL/Mp-lpr/lpr mice. J Immunol (1980) 2.89
Decline in suppressor T cell function with age in female NZB mice. J Immunol (1974) 2.79
Combination therapy with pulse cyclophosphamide plus pulse methylprednisolone improves long-term renal outcome without adding toxicity in patients with lupus nephritis. Ann Intern Med (2001) 2.77
Systemic autoimmune disease arises from polyclonal B cell activation. J Exp Med (1987) 2.71
Prostaglandin production by rheumatoid synovial cells: stimulation by a factor from human mononuclear Cells. J Exp Med (1977) 2.47
Biosynthesis of cyclic diterpenes in extracts from seedlings of Ricinus communis L. II. Conversion of geranylgeranyl pyrophosphate into diterpene hydrocarbons and partial purification of the cyclization enzymes. Biochemistry (1970) 2.45
Loss with age in NZB-W mice of thymic suppressor cells in the graft-vs-host reaction. J Immunol (1974) 2.45
Controlled trial of pulse methylprednisolone versus two regimens of pulse cyclophosphamide in severe lupus nephritis. Lancet (1992) 2.38
Selective loss of suppressor cell function in New Zealand mice induced by NTA. J Immunol (1977) 2.38
Corticosteroids inhibit prostaglandin production by rheumatiod synovia. Nature (1975) 2.33
The pathogenesis of autoimmunity in New Zealand mice, I. Induction of antinucleic acid antibodies by polyinosinic-polycytidylic acid. Proc Natl Acad Sci U S A (1969) 2.31
Studies of immune functions of patients with systemic lupus erythematosus. I. Dysfunction of suppressor T-cell activity related to impaired generation of, rather than response to, suppressor cells. Arthritis Rheum (1979) 2.28
Kaposi's sarcoma-associated herpesvirus encodes a bZIP protein with homology to BZLF1 of Epstein-Barr virus. J Virol (1999) 2.24
Early warning of rejection? Br Med J (1973) 2.22
Methylprednisolone and cyclophosphamide, alone or in combination, in patients with lupus nephritis. A randomized, controlled trial. Ann Intern Med (1996) 2.17
DNA-binding assay for detection of anti-DNA antibodies in NZB-NZW F1 mice. J Immunol (1969) 2.13
B-lymphocyte alloantigens associated with systemic lupus erythematosus. N Engl J Med (1978) 2.11
Evidence for novel cell cycle checkpoints in trypanosomes: kinetoplast segregation and cytokinesis in the absence of mitosis. J Cell Sci (1999) 2.07
Alterations in immunoregulatory T cell subsets in active systemic lupus erythematosus. J Clin Invest (1980) 2.06
Defective EBV-specific suppressor T-cell function in rheumatoid arthritis. N Engl J Med (1981) 2.05
Increased spontaneous activity of antibody-forming cells in the peripheral blood of patients with active SLE. Arthritis Rheum (1977) 2.03
Antihemostatic, antiinflammatory, and immunosuppressive properties of the saliva of a tick, Ixodes dammini. J Exp Med (1985) 1.97
Mapping of a gene causing familial Mediterranean fever to the short arm of chromosome 16. N Engl J Med (1992) 1.90
Biosynthesis of cyclic diterpenes in extracts from seedlings of Ricinus communis L. I. Identification of diterpene hydrocarbons formed from mevalonate. Biochemistry (1970) 1.89
Studies of immune functions of patients with systemic lupus erythematosus. Complement-dependent immunoglobulin M anti-thymus-derived cell antibodies preferentially inactivate suppressor cells. J Clin Invest (1979) 1.87
Effect of murine cytomegalovirus on the in vitro responses of T and B cells to mitogens. J Immunol (1976) 1.84
The cellular and genetic basis of murine lupus. Immunol Rev (1981) 1.75
The clearance and localization of nucleic acids by New Zealand and normal mice. Clin Exp Immunol (1972) 1.74
Cyclophosphamide in lupus nephritis: a controlled trial. Ann Intern Med (1971) 1.70
The pathogenesis of autoimmunity in New Zealand mice. 3. Factors influencing the formation of anti-nucleic acid antibodies. Immunology (1971) 1.68
Hematologic aspects of systemic lupus erythematosus. Current concepts. Ann Intern Med (1977) 1.68
Abnormally elevated frequency of Epstein-Barr virus-infected B cells in the blood of patients with rheumatoid arthritis. J Clin Invest (1984) 1.63
Bicyclists, helmets and head injuries: a rider-based study of helmet use and effectiveness. Am J Public Health (1988) 1.63
Autoimmunity--a perspective. Annu Rev Immunol (1983) 1.62
NIH conference. Rheumatoid arthritis: evolving concepts of pathogenesis and treatment. Ann Intern Med (1984) 1.61
Mechanism of allograft rejection in New Zealand mice. I. Cell synergy and its age-dependent loss. J Immunol (1973) 1.59
NIH conference. Systemic lupus erythematosus: evolving concepts. Ann Intern Med (1979) 1.59
Induction of immunologic tolerance in older New Zealand mice repopulated with young spleen, bone marrow, or thymus. J Exp Med (1970) 1.58
Prostaglandins in the rheumatic diseases. Ann N Y Acad Sci (1975) 1.58
The natural history and immunopathology of outbred athymic (nude) mice. Clin Immunol Immunopathol (1975) 1.57
Increased immunoglobulin-secreting cells in the blood of patients with active systemic lupus erythematosus. Am J Med (1980) 1.53
Prostaglandin synthesis by rheumatoid synovium and its stimulation by colchicine. Prostaglandins (1975) 1.53
Antivimentin antibodies are an independent predictor of transplant-associated coronary artery disease after cardiac transplantation. Transplantation (2001) 1.52
Approach to the study of the role of sex hormones in autoimmunity. Arthritis Rheum (1979) 1.51
Correlation between clinical activity of systemic lupus erythematosus and the amounts of DNA in DNA/anti-DNA antibody immune complexes. J Immunol (1982) 1.47
Presence of autoantibody for phospholipase inhibitory protein, lipomodulin, in patients with rheumatic diseases. Proc Natl Acad Sci U S A (1981) 1.47
Heterogeneity of immunoregulatory T-cell subsets in systemic lupus erythematosus. Correlation with clinical features. Am J Med (1982) 1.46
Platelet factor 4 injection produces acute pulmonary hypertension in the awake lamb. Anesthesiology (1995) 1.46
A defect of immunoregulatory T cell subsets in systemic lupus erythematosus patients demonstrated with anti-2H4 antibody. J Clin Invest (1987) 1.46
Studies of consomic mice bearing the Y chromosome of the BXSB mouse. J Immunol (1985) 1.44
Pathogenesis of autoimmunity in New Zealand mice. V. Loss of thymic suppressor function. Arthritis Rheum (1974) 1.42
Renal flares are common in patients with severe proliferative lupus nephritis treated with pulse immunosuppressive therapy: long-term followup of a cohort of 145 patients participating in randomized controlled studies. Arthritis Rheum (2002) 1.42
Fractionation of cells on a discontinuous Ficoll gradient. Study of subpopulations of human T cells using anti-T-cell antibodies from patients with systemic lupus erythematosus. J Clin Invest (1976) 1.41
Supressor cells in the graft vs host reaction. J Immunol (1973) 1.41
T cell abnormalities in NZB mice occur independently of autoantibody production. J Exp Med (1981) 1.40
Enhanced antibody response of mice to polyinosinic-polycytidylic acid by antithymocyte serum and its age-dependent loss in NZB-W mice. J Immunol (1973) 1.40
Studies of congenic MRL-Ipr/Ipr.xid mice. J Immunol (1983) 1.38
CS-A therapy in MRL-lpr/lpr mice: amelioration of immunopathology despite autoantibody production. J Immunol (1987) 1.38
Responder cells in the human autologous mixed lymphocyte reaction. J Clin Invest (1981) 1.37
Autoantibody to an immunoregulatory inducer population in patients with juvenile rheumatoid arthritis. J Clin Invest (1981) 1.37
The autologous mixed lymphocyte reaction in strains of mice with autoimmune disease. J Immunol (1980) 1.36
Marek's disease virus (MDV) encodes an interleukin-8 homolog (vIL-8): characterization of the vIL-8 protein and a vIL-8 deletion mutant MDV. J Virol (2001) 1.34
The identification of monoclonality in human aberrant crypt foci. Cancer Res (1999) 1.34
Human lymphocytes with either the OKT4 or OKT8 phenotype produce interleukin 2 in culture. J Clin Invest (1982) 1.33
Studies of T cell deletion and T cell anergy following in vivo administration of SEB to normal and lupus-prone mice. J Immunol (1993) 1.33
Relationship between systemic lupus erythematosus T cell subsets, anti-T cell antibodies, and T cell functions. J Clin Invest (1984) 1.32
Nucleic acid antibodies in African trypanosomiasis: studies in Rhesus monkeys and man. J Immunol (1974) 1.32
A novel CCCH protein which modulates differentiation of Trypanosoma brucei to its procyclic form. EMBO J (2001) 1.32
Immunofluorescence studies on thymocytotoxic antibody from New Zealand Black mice. J Immunol (1974) 1.31
Cyclophosphamide: use in practice. Ann Intern Med (1974) 1.31
Intramitochondrial localization of universal minicircle sequence-binding protein, a trypanosomatid protein that binds kinetoplast minicircle replication origins. J Cell Biol (2001) 1.31
Sex differences in formation of anti-T-cell antibodies. Nature (1976) 1.30
Ability of the xid gene to prevent autoimmunity in (NZB X NZW)F1 mice during the course of their natural history, after polyclonal stimulation, or following immunization with DNA. J Clin Invest (1982) 1.30
Efficacy of immunosuppressive drugs in rheumatic diseases. Arthritis Rheum (1973) 1.30
Acute polyarticular gout. Am J Med (1974) 1.29
Qualitative characteristics of anti-DNA antibodies in lupus nephritis. Arthritis Rheum (1975) 1.29
Genetic analysis of autoimmune gld mice. I. Identification of a restriction fragment length polymorphism closely linked to the gld mutation within a conserved linkage group. J Exp Med (1988) 1.28
Thromboxane receptor blockade prevents pulmonary hypertension induced by heparin-protamine reactions in awake sheep. Circulation (1990) 1.28
Complement-dependent alterations in the handling of immune complexes by NZB/W mice. J Immunol (1975) 1.28
A serum inhibitor of immune regulation in patients with systemic lupus erythematosus. J Clin Invest (1978) 1.27
The human autologous mixed lymphocyte reaction. III. Immune circuits. J Immunol (1982) 1.27
Autoimmunity and increased c-myb transcription. Science (1984) 1.27
The effects of salts on the free energy of the peptide group. J Am Chem Soc (1972) 1.27
The role of NZB-NZW F1 thymus in experimental tolerance and auto-immunity. Arthritis Rheum (1970) 1.27
In vitro correction of the interleukin 2 defect of autoimmune mice. Eur J Immunol (1983) 1.27